COMPARISONS OF RELATIVE RISKS OF SERIOUS COMORBIDITIES AMONG EMPLOYEES WITH AND WITHOUT INSOMNIA, GERD, HEPATITIS C, MULTIPLE SCLEROSIS, AND CHRONIC CONSTIPATION

Author(s)

Richard A. Brook, MS, MBA, Head, Retrospective Analysis1, Nathan L Kleinman, PhD, Director Research Services2, Arthur K Melkonian, MD, Research Analyst3, James Smeeding, RPh, MBA, President41The JeSTARx Group, Newfoundland, NJ, USA; 2 HCMS Group, Paso Robles, CA, USA; 3 The HCMS Group, Cheyenne, WY, USA; 4 The JeSTARx Group, Dallas, TX, USA

Objective: To compare the relative risks of 12 serious co-existing health conditions among employees with insomnia, gastroesophageal reflux disease (GERD), hepatitis C (HCV), multiple sclerosis (MS), or chronic constipation (CC). Methods: A 2001-2007 US employee database was used to identify subjects with insomnia, GERD, HCV, MS, or CC. For each condition, controls were matched on demographics, job-information, and geography. For each employee, 12-month post-index date medical claims were assigned to 261 Agency for Healthcare Research and Quality (AHRQ) condition categories using ICD-9 codes. Prevalence of these conditions was compared between the five pairs of matched disease/non-disease cohorts. Results: Numbers of employees with disease and matched employees without disease were: Insomnia 17,230/17,230; GERD 11,653/116,530; HCV 1,329/26,580; MS 765/15,300; CC 1,215/29,160. Of the 261 AHRQ categories, insomnia employees had significantly higher prevalence than controls in 201 and significantly lower prevalence in two categories. Numbers of categories with higher/lower prevalence in the GERD, HCV, MS, and CC populations compared to their respective controls were 197/7, 126/0, 96/0, and 148/0, respectively. Relative risks of coronary atherosclerosis among employees with insomnia, GERD, HCV, MS, or CC (relative to employees without these diseases) were 1.8*, 2.2*, 1.3*, 1.7*, and 1.6*, respectively. Similarly, respective relative risks were calculated for essential hypertension (1.5*, 1.6*, 1.2*, 1.1, 1.3*), hyperlipidemia (1.6*, 1.8*, 0.9, 1.2*, 1.7*), acute cerebrovascular disease (3.4*, 2.3*, 0.9, 7.8*, 2.5*), diabetes without complications (1.4*, 1.4*, 1.5*, 0.9, 1.2), diabetes with complications (1.3*, 1.3*, 1.9*, 0.9, 1.5*), chronic obstructive pulmonary disease (2.0*, 2.0*, 1.7*, 1.4, 1.4*), asthma (2.1*, 2.5*, 1.3, 1.1, 1.6*), rheumatoid arthritis (2.0*, 2.1*, 2.5*, 1.8, 2.9*), osteoarthritis (2.2*, 2.1*, 1.6*, 1.3, 1.8*), osteoporosis (1.7*, 1.7*, 1.4, 2.6*, 2.3*), and neoplasms (1.4*, 1.8*, 1.5*, 1.4*, 2.0*) (*P<0.05). Conclusion: Employees with insomnia, GERD, HCV, MS, or CC have many more serious co-morbidities than employees without these diseases.

Conference/Value in Health Info

2008-05, ISPOR 2008, Toronto, Ontario, Canada

Value in Health, Vol. 11, No. 3 (May/June 2008)

Code

PHP51

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Hospital and Clinical Practices

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×